Company Filing History:
1 out of 71 
1 out of 378 
Years Active: 2009-2012
Title: Issei Kato: Innovator in Pharmaceutical Chemistry
Introduction
Issei Kato is a prominent inventor based in Nara, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on fused azole-pyrimidine derivatives. With a total of 2 patents, Kato's inventions are paving the way for new treatments in various medical conditions.
Latest Patents
Kato's latest patents focus on novel fused azole-pyrimidine derivatives. These compounds exhibit enhanced potency for phosphatidylinositol-3-kinase (PI3K) inhibition, especially for PI3K-γ inhibition. They can be utilized for the prophylaxis and treatment of diseases associated with PI3K activity, including inflammatory and immunoregulatory disorders such as asthma, atopic dermatitis, and chronic obstructive pulmonary disease (COPD). Additionally, these derivatives are beneficial for treating cancer, heart failure, and neurodegenerative disorders like Parkinson's and Alzheimer's diseases.
Career Highlights
Throughout his career, Issei Kato has worked with notable companies, including Bayer Pharmaceuticals Corporation and Bayer Pharma Aktiengesellschaft. His work has significantly impacted the pharmaceutical industry, particularly in developing new therapeutic agents.
Collaborations
Kato has collaborated with esteemed colleagues such as Mitsuyuki Shimada and Toshiki Murata. These partnerships have further enhanced his research and development efforts in pharmaceutical innovations.
Conclusion
Issei Kato's contributions to pharmaceutical chemistry through his innovative patents are noteworthy. His work continues to influence the development of new treatments for various diseases, showcasing the importance of innovation in healthcare.